Details for New Drug Application (NDA): 062002
✉ Email this page to a colleague
NDA 062002 describes PENAPAR-VK, which is a drug marketed by Parke Davis and is included in two NDAs. Additional details are available on the PENAPAR-VK profile page.
The generic ingredient in PENAPAR-VK is penicillin v potassium. There are ninety-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
The generic ingredient in PENAPAR-VK is penicillin v potassium. There are ninety-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
Summary for 062002
| Tradename: | PENAPAR-VK |
| Applicant: | Parke Davis |
| Ingredient: | penicillin v potassium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 125MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 250MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
